Vasospasm in cerebral inflammation

International Journal of Inflammation

Volumn 2014, Issue , 2014, Pages

  Eisenhut, Michael ^a  

^a BEDFORD HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AUTACOID; CALCIUM; CALCIUM ANTAGONIST; CLAZOSENTAN; CORTICOSTEROID; DOBUTAMINE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; FASUDIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INTERLEUKIN 1; MAGNESIUM SULFATE; MELOXICAM; MYOSIN LIGHT CHAIN KINASE; NICARDIPINE; NITRIC OXIDE; PIROXICAM; PLACEBO; RECOMBINANT PLASMINOGEN ACTIVATOR; SODIUM NITRITE; UROKINASE;

BACTERIAL MENINGITIS; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN MALARIA; BRAIN VASOSPASM; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DEPLETION; DISEASE ASSOCIATION; DRUG POTENTIATION; ENCEPHALITIS; HUMAN; INTRACRANIAL DRUG ADMINISTRATION; MORTALITY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUBARACHNOID HEMORRHAGE; TUBERCULOUS MENINGITIS;

EID: 84921044808     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2014/509707     Document Type: Review

References (109)

1. B. Weir, "The pathophysiology of cerebral vasospasm," British Journal of Neurosurgery, vol. 9, no. 3, pp. 375-390, 1995.
2. H. Bode and A. Harders, "Transient stenoses and occlusions of main cerebral arteries in children-diagnosis and control of therapy by transcranial Doppler sonography," European Journal of Pediatrics, vol. 148, no. 5, pp. 406-411, 1989.
3. K.-F. Lindegaard, H. Nornes, S. J. Bakke, W. Sorteberg, and P. Nakstad, "Cerebral vasospasm diagnosis bymeans of angiography and blood velocity measurements," Acta Neurochirurgica, vol. 100, no. 1-2, pp. 12-24, 1989.
4. C. Lysakowski, B. Walder, M. C. Costanza, and M. R. Tramèr, "Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review," Stroke, vol. 32, no. 10, pp. 2292-2298, 2001.
5. R. L. Grubb Jr. , M. E. Raichle, J. O. Eichling, and M. H. Gado, "Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow and oxygen utilization in humans," Journal of Neurosurgery, vol. 46, no. 4, pp. 446-452, 1977.
6. C.-H. Lu, H.-W. Chang, C.-C. Lui, C.-R. Huang, and W.-N. Chang, "Cerebral haemodynamics in acute bacterialmeningitis in adults," Quaterly Journal ofMedicine, vol. 99, no. 12, pp. 863- 869, 2006.
7. F. Faraci and D. D. Heistad, "Regulation of the cerebral circulation: role of endothelium and potassium channels," Physiological Reviews, vol. 78, no. 1, pp. 53-97, 1998.
8. L. Hektoen, "The vascular changes in tuberculous meningitis especially in tuberculous endarteritis," Journal of Experimental Medicine, vol. 1, pp. 112-163, 1896.
9. G. Thwaites, "Tuberculosis of the central nervous system," in Clinical Tuberculosis, P. D. O. Davies, S. B. Gordon, and G. Davies, Eds. , pp. 151-165, CRC Press, 5th edition, 2014.
10. P. M. Dalal, "Observations on the involvement of cerebral vessels in tuberculousmeningitis in adults," Advances in Neurology, vol. 25, pp. 149-159, 1979.
11. L. A. Rojas-Echeverri, J. L. Soto-Hernández, S. Garza et al. , "Predictive value of digital subtraction angiography in patients with tuberculous meningitis," Neuroradiology, vol. 38, no. 1, pp. 20-24, 1996.
12. E. L. Lyons and N. E. Leeds, "The angiographic demonstration of arterial vascular disease in purulent meningitis: report of a case," Radiology, vol. 88, no. 5, pp. 935-938, 1967.
13. S. Ries, U. Schminke, K. Fassbender, M. Daffertshofer, W. Steinke, and M. Hennerici, "Cerebrovascular involvement in the acute phase of bacterial meningitis," Journal of Neurology, vol. 244, no. 1, pp. 51-55, 1997.
14. K. Fassbender, S. Ries, U. Schminke, S. Schneider, and M. Hennerici, "Inflammatory cytokines in CSF in bacterial meningitis: association with altered blood flow velocities in basal cerebral arteries," Journal of Neurology, Neurosurgery and Psychiatry, vol. 61, no. 1, pp. 57-61, 1996.
15. L. A. Pfister, J. H. Tureen, S. Shaw et al. , "Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis," Annals of Neurology, vol. 47, pp. 329-335, 2000.
16. S. L. Leib, Y. S. Kim, S. M. Black, J. H. Tureen, and M. G. Täuber, "Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis," The Journal of Infectious Diseases, vol. 177, no. 3, pp. 692-700, 1998.
17. T. W. Polder, C. R. Jerusalem, and W. M. C. Eling, "Morphological characteristics of intracerebral arterioles in clinical (Plasmodium falciparum) and experimental (Plasmodium berghei) cerebral malaria," Journal of the Neurological Sciences, vol. 101, no. 1, pp. 35-46, 1991.
18. N. A. V. Beare, S. P. Harding, T. E. Taylor, S. Lewallen, and M. E. Molyneux, "Perfusion abnormalities in children with cerebral malaria and malarial retinopathy," Journal of InfectiousDiseases, vol. 199, no. 2, pp. 263-271, 2009.
19. C. R. J. C. Newton, K. Marsh, N. Peshu, and F. J. Kirkham, "Perturbations of cerebral hemodynamics in Kenyans with cerebral malaria," Pediatric Neurology, vol. 15, no. 1, pp. 41-49, 1996.
20. C. C. John, A. Panoskaltsis-Mortari, R. O. Opoka et al. , "Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria," American Journal of Tropical Medicine and Hygiene, vol. 78, no. 2, pp. 198-205, 2008.
21. W. McGuire, A. V. S. Hill, C. E. M. Allsopp, B. M. Greenwood, and D. Kwiatkowski, "Variation in the TNF-promoter region associated with susceptibility to cerebral malaria," Nature, vol. 371, no. 6497, pp. 508-510, 1994.
22. W. McGuire, J. C. Knight, A. V. S. Hill, C. E. M. Allsopp, B. M. Greenwood, and D. Kwiatkowski, "Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles," Journal of Infectious Diseases, vol. 179, no. 1, pp. 287-290, 1999.
23. B. Dugas, M. D. Mossalayi, C. Damais, and J.-P. Kolb, "Nitric oxide production by human monocytes: Evidence for a role of CD23," Immunology Today, vol. 16, no. 12, pp. 574-580, 1995.
24. L. Pellettieri, B. Nilsson, C.-A. Carlsson, and U. Nilsson, "Serum immunocomplexes in patients with subarachnoid hemorrhage," Neurosurgery, vol. 19, no. 5, pp. 767-771, 1986.
25. M. Eisenhut, "Causes of reduced immune complex clearance in cerebralmalaria," Parasite Immunology, vol. 31, no. 2, p. 59, 2009.
26. P. Teeranaipong, J. Ohashi, J. Patarapotikul et al. , "A functional single-nucleotide polymorphism in the CR1 promoter region contributes to protection against cerebral malaria," Journal of Infectious Diseases, vol. 198, no. 12, pp. 1880-1891, 2008.
27. P. Cabrales, G. M. Zanini, D. Meays, J. A. Frangos, and L. J. M. Carvalho, "Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine," The American Journal of Pathology, vol. 176, no. 3, pp. 1306-1315, 2010.
28. I. Gramaglia, P. Sobolewski, D. Meays et al. , "Low nitric oxide bioavailability contributes to the genesis of experimental cerebralmalaria," Nature Medicine, vol. 12, no. 12, pp. 1417-1422, 2006.
29. T. W. Yeo, D. A. Lampah, E. Tjitra et al. , "Relationship of cellfree hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria," Journal of Infectious Diseases, vol. 200, no. 10, pp. 1522-1529, 2009.
30. G. Dhangadamajhi, B. N. Mohapatra, S. K. Kar, and M. Ranjit, "Genetic variation in neuronal nitric oxide synthase (nNOS) gene and susceptibility to cerebral malaria in Indian adults," Infection, Genetics and Evolution, vol. 9, no. 5, pp. 908-911, 2009.
31. M. R. Hobbs, V. Udhayakumar, M. C. Levesque et al. , "A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children," The Lancet, vol. 360, no. 9344, pp. 1468-1475, 2002.
32. P. Cabrales, G. M. Zanini, D. Meays, J. A. Frangos, and L. J. M. Carvalho, "Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology," The Journal of Infectious Diseases, vol. 203, no. 10, pp. 1454-1463, 2011.
33. G. Morahan, C. S. Boutlis, D. Huang et al. , "A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production," Genes and Immunity, vol. 3, no. 7, pp. 414-418, 2002.
34. C. Casals-Pascual, R. Idro, N. Gicheru et al. , "High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebralmalaria," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 7, pp. 2634-2639, 2008.
35. F. C. Chow, C. M. Marra, and T. A. Cho, "Cerebrovascular disease in central nervous system infections," Seminars in Neurology, vol. 31, no. 3, pp. 286-306, 2011.
36. R. A. Armonda, R. S. Bell, A. H. Vo et al. , "Wartime traumatic cerebral vasospasm: recent review of combat casualties," Neurosurgery, vol. 59, no. 6, pp. 1215-1225, 2006.
37. K. Shahlaie, K. Keachie, I. M. Hutchins et al. , "Risk factors for posttraumatic vasospasm: clinical article," Journal of Neurosurgery, vol. 115, no. 3, pp. 602-611, 2011.
38. Y. Udomphorn, W. M. Armstead, and M. S. Vavilala, "Cerebral blood flow and autoregulation after pediatric traumatic brain injury," Pediatric Neurology, vol. 38, no. 4, pp. 225-234, 2008.
39. R. M. Pluta, J. Hansen-Schwartz, J. Dreier et al. , "Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought," Neurological Research, vol. 31, no. 2, pp. 151- 158, 2009.
40. J. Hansen-Schwartz, P. Vajkoczy, R. L. Macdonald, R. M. Pluta, and J. H. Zhang, "Cerebral vasospasm: looking beyond vasoconstriction," Trends in Pharmacological Sciences, vol. 28, no. 6, pp. 252-256, 2007.
41. H. Kasuya, B. K. A. Weir, M. Nakane et al. , "Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage," Journal of Neurosurgery, vol. 82, no. 2, pp. 250-255, 1995.
42. M. D. Linnik and T. J. F. Lee, "Effect of hemoglobin on neurogenic responses and cholinergic parameters in porcine cerebral arteries," Journal of Cerebral Blood Flow and Metabolism, vol. 9, no. 2, pp. 219-225, 1989.
43. C. G. Sobey and F. M. Faraci, "Subarachnoid haemorrhage:what happens to the cerebral arteries?" Clinical and Experimental Pharmacology and Physiology, vol. 25, no. 11, pp. 867-876, 1998.
44. Y. R. T. Dinh, G. Lot, R. Benrabah, O. Baroudy, J. Cophignon, and J. Seylaz, "Abnormal cerebral vasodilation in aneurysmal subarachnoid hemorrhage: use of serial 133Xe cerebral blood flow measurement plus acetazolamide to assess cerebral vasospasm," Journal of Neurosurgery, vol. 79, no. 4, pp. 490-493, 1993.
45. T. J. F. Lee, "Nitric oxide and the cerebral vascular function," Journal of Biomedical Science, vol. 7, no. 1, pp. 16-26, 2000.
46. M. Stoodley, R. L. Macdonald, B. Weir et al. , "Subarachnoid hemorrhage as a cause of an adaptive response in cerebral arteries," Journal of Neurosurgery, vol. 93, no. 3, pp. 463-470, 2000.
47. Y. R. Tran Dinh, A. Jomaa, J. Callebert et al. , "Overexpression of cyclooxygenase-2 in rabbit basilar artery endothelial cells after subarachnoid hemorrhage," Neurosurgery, vol. 48, no. 3, pp. 626-635, 2001.
48. Á. Gecse B. Kis Z. Mezei G. Telegdy, Effects of inflammatory neuropeptides on the arachidonate cascade of platelets, International Archives of Allergy and Immunology, 118, 2, 4, 166-170, 1999.
49. K. S. Mark, W. J. Trickler, and D. W. Miller, "Tumor necrosis factor-induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells," Journal of Pharmacology and Experimental Therapeutics, vol. 297, no. 3, pp. 1051-1058, 2001.
50. T. Tanazawa, Y. Suzuki, M. Anzai, S. Tsugane, M. Takayasu, and M. Shibuya, "Vasodilation by intrathecal lipopolysaccharide of the cerebral arteries after subarachnoid haemorrhage in dogs," Acta Neurochirurgica, vol. 138, no. 3, pp. 330-337, 1996.
51. N. Toda, M. Kawakami, and K. Yoshida, "Constrictor action of oxyhemoglobin in monkey and dog basilar arteries in vivo and in vitro," American Journal of Physiology: Heart and Circulatory Physiology, vol. 260, no. 2, pp. H420-H425, 1991.
52. M. Yoshizumi, M. A. Perrella, J. C. Burnett Jr. , and M.-E. Lee, "Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life," Circulation Research, vol. 73, no. 1, pp. 205-209, 1993.
53. A. Rengasamy and R. A. Johns, "Regulation of nitric oxide synthase by nitric oxide," Molecular Pharmacology, vol. 44, no. 1, pp. 124-128, 1993.
54. A. L. de Souza, A. C. P. de Oliveira, C. C. Romano, J. Sztajnbok, A. J. S. Duarte, and A. C. Seguro, "Interleukin-6 activation in ischemic stroke caused by Neisseria meningitidis serogroup C," International Journal of Cardiology, vol. 127, no. 3, pp. e160-e163, 2008.
55. T. Kandabashi, H. Shimokawa, K. Miyata et al. , "Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin- 1β," Circulation, vol. 101, no. 11, pp. 1319-1323, 2000.
56. D.-H. Nam, J.-S. Kim, S.-C. Hong et al. , "Expression of interleukin-1β in lipopolysaccharide stimulated monocytes derived from patients with aneurysmal subarachnoid hemorrhage is correlated with cerebral vasospasm," Neuroscience Letters, vol. 312, no. 1, pp. 41-44, 2001.
57. A. Ito, H. Shimokawa, T. Kadokami et al. , "Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1β in pigs in vivo," Journal of Clinical Investigation, vol. 96, no. 3, pp. 1288-1294, 1995.
58. H. Yanamoto, H. Kataoka, Y. Nakajo, and K. Iihara, "The role of the host defense system in the development of cerebral vasospasm: analogies between atherosclerosis and subarachnoid hemorrhage," European Neurology, vol. 68, no. 6, pp. 329- 343, 2012.
59. A. F. Ducruet, P. R. Gigante, Z. L. Hickman et al. , "Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage," Journal of Cerebral Blood Flow & Metabolism, vol. 30, no. 4, pp. 676-688, 2010.
60. J. Langham, C. Goldfrad, G. Teasdale, D. Shaw, and K. Rowan, "Calcium channel blockers for acute traumatic brain injury," Cochrane Database Systematic Reviews, no. 4, Article ID CD000565, 2000.
61. S. M. Dorhout Mees, G. J. Rinkel, V. L. Feigin et al. , "Calcium antagonists for aneurysmal subarachnoid haemorrhage," Cochrane Database of Systematic Reviews, no. 3, Article ID CD000277, 2007.
62. R.-Q. Huang, F.-G. Jiang, Z.-M. Feng, and T.-Y. Wang, "Nicardipine in the treatment of aneurysmal subarachnoid haemorrhage: a meta-analysis of published data," Acta Neurologica Belgica, vol. 113, no. 1, pp. 3-6, 2013.
63. S. Naidu, A. J. Payne, J. Moodley, M. Hoffmann, and E. Gouws, "Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound," British Journal of Obstetrics & Gynaecology, vol. 103, no. 2, pp. 111-116, 1996.
64. D. Reddy, A. Fallah, J.-A. Petropoulos, F. Farrokhyar, R. L. Macdonald, and D. Jichici, "Prophylactic magnesium sulphate for aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis," Neurocritical Care, vol. 21, no. 2, pp. 356- 364, 2014.
65. C. M. Bradford, S. Finfer, A. OConnor et al. , "A randomised controlled trial of induced hypermagnesaemia following aneurysmal subarachnoid haemorrhage," Critical Care and Resuscitation, vol. 15, no. 2, pp. 119-125, 2013.
66. S.-H. Su, W. Xu, J. Hai, Y.-F. Wu, and F. Yu, "Effects of statinsuse for patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials," Scientific Reports, vol. 4, article 4573, 2014.
67. J. Guo, Z. Shi, K. Yang, J. H. Tian, and L. Jiang, "Endothelin receptor antagonists for subarachnoid hemorrhage," Cochrane Database of Systematic Reviews, vol. 9, Article ID CD008354, 2012.
68. J. Shen, J.-W. Pan, Z.-X. Fan, X.-X. Xiong, and R.-Y. Zhan, "Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials: a review," Journal of Neurosurgery, vol. 119, no. 1, pp. 180- 189, 2013.
69. P. Gomis, J. P. Graftieaux, R. Sercombe, D. Hettler, B. Scherpereel, and P. Rousseaux, "Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage," Journal of Neurosurgery, vol. 112, no. 3, pp. 681-688, 2010.
70. A. H. Kramer and J. J. Fletcher, "Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis," Neurocritical Care, vol. 14, no. 3, pp. 489-499, 2011.
71. G. J. Liu, Z. J. Wang, Y. F. Wang et al. , "Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage," European Journal of Clinical Pharmacology, vol. 68, no. 2, pp. 131-139, 2012.
72. S. Zhang, L. Wang, M. Liu, and B. Wu, "Tirilazad for aneurysmal subarachnoid haemorrhage," Cochrane Database Systematic Review, vol. 2, Article IDCD006778, 2010.
73. M.-Y. Tseng, P. J. Hutchinson, H. K. Richards et al. , "Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a phase II randomized, double-blind, placebo-controlled trial: clinical article," Journal of Neurosurgery, vol. 111, no. 1, pp. 171- 180, 2009.
74. H. Kasuya, "Development of nicardipine prolonged-release implants after clipping for preventing cerebral vasospasm: from laboratory to clinical trial," Acta Neurochirurgica, Supplementum, vol. 115, pp. 41-44, 2013.
75. C. Thomé, M. Seiz, G. A. Schubert et al. , "Nicardipine pellets for the prevention of cerebral vasospasm," Acta Neurochirurgica, no. 110, pp. 209-211, 2011.
76. T. Nassar, S. Akkawi, A. Shina et al. , "In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone," Blood, vol. 103, no. 3, pp. 897-902, 2004.
77. T. Sugawara, R. Ayer, V. Jadhav, W. Chen, T. Tsubokawa, and J. H. Zhang, "Mechanisms of statin treatment in cerebral vasospasm," Acta Neurochirurgica, no. 110, pp. 9-11, 2011.
78. M. D. Vergouwen, R. J. De Haan, M. Vermeulen, and Y. B. Roos, "Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update," Stroke, vol. 41, no. 1, pp. e47-e52, 2010.
79. G. E. Thwaites, N. D. Bang, N. H. Dung et al. , "Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults,"The New England Journal ofMedicine, vol. 351, no. 17, pp. 1741-1811, 2004.
80. G. E. Thwaites, J. Macmullen-Price, T. T. H. Chau et al. , "Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study," The Lancet Neurology, vol. 6, no. 3, pp. 230-236, 2007.
81. U. K. Misra, J. Kalita, and P. P. Nair, "Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial," Journal of the Neurological Sciences, vol. 293, no. 1-2, pp. 12-17, 2010.
82. P. W. G. Elbers and C. Ince, "Bench-to-bedside review: mechanisms of critical illness-classifying microcirculatory flow abnormalities in distributive shock," Critical Care, vol. 10, article 221, 2006.
83. S. Trzeciak, I. Cinel, R. P. Dellinger et al. , "Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials," Academic Emergency Medicine, vol. 15, no. 5, pp. 399-415, 2008.
84. Y. Sakr, M.-J. Dubois, D. De Backer, J. Creteur, and J.-L. Vincent, "Persistent-microcirculatory alterations are associated with organ failure and death in patients with septic shock," Critical Care Medicine, vol. 32, no. 9, pp. 1825-1831, 2004.
85. P. E. Spronk, J. H. Rommes, C. Schaar, and C. Ince, "Thrombolysis in fulminant purpura: observations on changes in microcirculatory perfusion during succesful treatment," Thrombosis and Haemostasis, vol. 95, no. 3, pp. 576-578, 2006.
86. J. Creteur, D. De Backer, Y. Sakr, M. Koch, and J.-L. Vincent, "Sublingual capnometry tracks microcirculatory changes in septic patients," Intensive Care Medicine, vol. 32, no. 4, pp. 516- 523, 2006.
87. D. De Backer, J. Creteur, J. C. Preiser, M. J. Dubois, and J. L. Vincent, "Microvascular blood flow is altered in patients with sepsis," American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 1, pp. 98-104, 2002.
88. G. M. Ibrahim and R. L. Macdonald, "The effects of fluid balance and colloid administration on outcomes in patients with aneurysmal subarachnoid hemorrhage: a propensity scorematched analysis," Neurocritical Care, vol. 19, no. 2, pp. 140-149, 2013.
89. T. W. Yeo, D. A. Lampah, R. Gitawati et al. , "Impaired nitric oxide bioavailability and L-arginine-reversible endothelial dysfunction in adults with falciparum malaria," The Journal of Experimental Medicine, vol. 204, no. 11, pp. 2693-2704, 2007.
90. A. R. Fathi, R. M. Pluta, K. D. Bakhtian, M. Qi, and R. R. Lonser, "Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates: laboratory investigation," Journal of Neurosurgery, vol. 115, no. 6, pp. 1213- 1220, 2011.
91. D. de Backer, J. Creteur, M. J. Dubois et al. , "The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects," Critical Care Medicine, vol. 34, no. 2, pp. 403-408, 2006.
92. C. E. Chapleau, R. P. White, and J. T. Robertson, "Cerebral vasospasm: effects of prostaglandin synthetase inhibitors in vitro," Neurosurgery, vol. 6, no. 2, pp. 155-159, 1980.
93. J. L. Frazier, G. Pradilla, P. P. Wang, and R. J. Tamargo, "Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage," Journal of Neurosurgery, vol. 101, no. 1, pp. 93-98, 2004.
94. G. Pradilla, Q. A. Thai, F. G. Legnani et al. , "Local delivery of ibuprofen via controlled-release polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage," Neurosurgery, vol. 57, no. 1, pp. 184-189, 2005.
95. R. P. White and J. T. Robertson, "Comparison of piroxicam, meclofenamate, ibuprofen, aspirin, and prostacyclin efficacy in a chronic model of cerebral vasospasm," Neurosurgery, vol. 12, no. 1, pp. 40-46, 1983.
96. T. Fukumori, E. Tani, Y. Maeda, and A. Sukenaga, "Effects of prostacyclin and indomethacin on experimental delayed cerebral vasospasm," Journal of Neurosurgery, vol. 59, no. 5, pp. 829-834, 1983.
97. L. Brandt, B. Ljunggren, K.-E. and ersson, B. Hindfelt, and T. Uski, "Prostaglandin metabolism and prostacyclin in cerebral vasospasm," General Pharmacology, vol. 14, no. 1, pp. 141-143, 1983.
98. T. Hakan, M. Zafer Berkman, T. Ersoy, I. Karatas, T. San, and S. Arbak, "Anti-inflammatory effect of meloxicam on experimental vasospasm in the rat femoral artery," Journal of Clinical Neuroscience, vol. 15, no. 1, pp. 55-59, 2008.
99. L. G. Toussaint III, J. A. Friedman, E. F. M. Wijdicks et al. , "Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage," Journal of Neurosurgery, vol. 101, no. 6, pp. 921- 925, 2004.
100. B. A. Gross, P. M. R. Lai, K. U. Frerichs, and R. Du, "Aspirin and aneurysmal subarachnoid haemorrhage," World Neurosurgery, 2013.
101. S. Yokobori, A. Watanabe, R. Nakae et al. , "Cerebral vasospasms after intraventricular hemorrhage from an arteriovenous malformation-case report," Neurologia Medico-Chirurgica, vol. 50, no. 4, pp. 320-323, 2010.
102. B. S. Park, Y. S. Won, S. S. Choi, and B. M. Kim, "Severe symptomatic vasospasm following intraventricular hemorrhage from arteriovenous fistula," Journal of Korean Neurosurgical Society, vol. 45, no. 5, pp. 300-302, 2009.
103. G. Pradilla, T. Garzon-Muvdi, J. J. Ruzevick et al. , "Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage,"Neurosurgery, vol. 70, no. 3, pp. 747-757, 2012.
104. G. Chen, J. Wu, C. Sun et al. , "Potential role of JAK2 in cerebral vasospasm after experimental subarachnoid hemorrhage," Brain Research, vol. 1214, pp. 136-144, 2008.
105. C. L. Lin, A. L. Kwan, A. S. Dumont et al. , "Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303," Journal of Neurosurgery, vol. 106, no. 3, pp. 442-448, 2007.
106. K. Iseda, S. Ono, K. Onoda et al. , "Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage," Journal of Neurosurgery, vol. 107, no. 1, pp. 128-135, 2007.
107. C.-L. Lin, A. S. Dumont, T. Calisaneller, A.-L. Kwan, S.- L. Hwong, and K. S. Lee, "Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm," SurgicalNeurology, vol. 64, no. 3, pp. 201-206, 2005.
108. R. Echigo, N. Shimohata, K. Karatsu et al. , "Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage," Journal of Translational Medicine, vol. 10, no. 1, article 80, 2012.
109. C. Wakade, M. D. King, M. D. Laird, C. H. Alleyne Jr. , and K. M. Dhandapani, "Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice," Antioxidants & Redox Signaling, vol. 11, no. 1, pp. 35-45, 2009.